Investment Companies to Include Contractual Sale Restrictions in Fair Value of Equity Securities
BY ACCESSING THE FASB DOCUMENTS ON THIS SITE, YOU ACCEPT AND AGREE TO THESE FASB TERMS AND THE WEBSITE TERMS AS APPLIED TO YOUR USE OF THIS SITE OR ANY FASB LICENSED DOCUMENTS.
The Financial Accounting Standards Board (FASB) has issued Accounting Standards Update (ASU) 2026-03, Fair Value Measurement (Topic 820): Investment Companies with Equity Securities Subject to Contractual Sale Restrictions. The update is a narrow exception to ASC 820, Fair Value Measurement, applying only to investment companies within the scope of ASC 946, Financial Services — Investment Companies. It requires investment companies within the scope of ASC 946 to consider contractual sale restrictions when measuring the fair value of equity securities in accordance with ASC 820. (Other entities must continue to exclude contractual sale restrictions from fair value.) It also requires investment companies to disclose the amount of the discount attributable to the restriction.
Key Takeaways
- Investment companies within the scope of ASC 946 must now apply a discount (and disclose the amount of that discount) to reflect the amount market participants would demand because of a contractual sale restriction, reversing the guidance in ASU 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions, for these entities.
- Restrictions already reflected in the economics of another transaction, such as securities pledged as collateral in a borrowing, are excluded to avoid double counting the same economic effect.
- Transition is prospective to all equity securities, including those with restrictions already in effect, with the adoption adjustment recognized in current-period earnings and disclosed.
- Early adoption is permitted any date on or after September 9, 2026.
Why Is U.S. GAAP Changing?
Under ASC 820, a contractual restriction on the sale of an equity security is not part of the security’s unit of account and therefore is not considered in measuring fair value. ASC 820 also prohibits an entity from recognizing and measuring a contractual sale restriction as a separate unit of account. As a result, under ASC 820, an entity holding a contractually restricted equity security and an entity holding an identical unrestricted security issued by the same investee (and for which there are quoted prices in an active market) each measure fair value based on the market price of the unrestricted security.
Stakeholders indicated that the existing guidance produces fair value measurements that do not accurately reflect how market participants would value equity securities subject to contractual sale restrictions — a concern emphasized for investment companies because excluding the effect of those restrictions in the fair value measurement (i) overstates net asset value (NAV), (ii) might distort performance reporting and management fees, and (iii) creates different outcomes for purchasing, redeeming and remaining shareholders.
Who Does This Change Affect?
The amendments in ASU 2026-03 only apply to investment companies within the scope of ASC 946 that have investments in equity securities that are subject to contractual sale restrictions. The amendments are a narrow exception, meaning that all other entities must continue to ignore the effect of contractual sale restrictions in the fair value measurement of equity securities, in accordance with the existing guidance in ASC 820.
What Is Changing?
Measurement Exception for Investment Companies
When an investment company cannot sell an equity security on the measurement date because of a contractual sale restriction, ASU 2026-03 requires the investment company to apply a discount for the effect of the restriction in the fair value measurement of that security. Specifically, the investment company applies the discount regardless of whether the contractual sale restriction is (i) a characteristic of the reporting entity holding the security or (ii) a characteristic of the security itself. The discount reflects the amount that market participants would demand to compensate for the liquidity risk and price volatility associated with the restriction period. The requirement does not apply to restrictions imposed on equity securities that are reflected in the economics of another transaction entered by the reporting entity (for example, a borrowing in which the reporting entity pledged those equity securities as collateral).
New Disclosure of the Discount
ASU 2026-03 requires investment companies to disclose the amount of the discount included in the fair value measurement of equity securities that is attributable to contractual sale restrictions. If an entity has multiple investments in equity securities subject to contractual sale restrictions, it considers the guidance in ASC 820-10-50-1D to determine how much to aggregate or disaggregate the disclosed information. The new disclosure is in addition to the existing fair value disclosures that equity securities subject to contractual sale restrictions are required to provide. Therefore, entities must still disclose the nature of the restrictions, the remaining duration of the restrictions, and circumstances that could cause a lapse.
When Are The Changes Effective?
The following table summarizes the transition for ASU 2026-03:
| PUBLIC BUSINESS ENTITIES | ALL OTHER ENTITIES | |
|---|---|---|
| Effective Date |
| |
| Early adoption | Permitted on any date on or after September 9, 2026. | |
| Transition |
| |
Link to ASU 2026-03.